FDA approves new nasal spray to treat potentially life-threatening allergic reactions

On Friday, the FDA approved Neffy, the first nasal spray to be used as an emergency treatment for the tens of millions of Americans at risk of potentially life-threatening allergic reactions. CBS News medical contributor Dr. Celine Gounder explains what to know about the new needle-free alternative to the EpiPen.

Each weekday morning, "CBS Mornings" co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.

Subscribe to "CBS Mornings" on YouTube:    / cbsmornings  
Watch CBS News 24/7: https://cbsnews.com/live/
Download the CBS News app: https://cbsnews.com/mobile/
Follow "CBS Mornings" on Instagram:   / cbsmornings  
Like "CBS Mornings" on Facebook:   / cbsmornings  
Follow "CBS Mornings" on X:   / cbsmornings  
Subscribe to our newsletter: https://cbsnews.com/newsletters/
Try Paramount+ free: https://paramountplus.com/?ftag=PPM-0...

For video licensing inquiries, contact: [email protected]